These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28153754)

  • 21. Effect of Zoledronic Acid Application on Different Graft Materials in Calvarial Bone Defect Models. An Experimental Analysis.
    Koparal M; Gülsün B; Deveci E; Agacayak KS; Hamidi A
    Anal Quant Cytopathol Histpathol; 2016 Apr; 38(2):117-25. PubMed ID: 27386633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endogenous Msx1 antisense transcript: in vivo and in vitro evidences, structure, and potential involvement in skeleton development in mammals.
    Blin-Wakkach C; Lezot F; Ghoul-Mazgar S; Hotton D; Monteiro S; Teillaud C; Pibouin L; Orestes-Cardoso S; Papagerakis P; Macdougall M; Robert B; Berdal A
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7336-41. PubMed ID: 11390985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the dlx gene family during formation of the cranial bones in the zebrafish (Danio rerio): differential involvement in the visceral skeleton and braincase.
    Verreijdt L; Debiais-Thibaud M; Borday-Birraux V; Van der Heyden C; Sire JY; Huysseune A
    Dev Dyn; 2006 May; 235(5):1371-89. PubMed ID: 16534783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Msx1 and Dlx5 act independently in development of craniofacial skeleton, but converge on the regulation of Bmp signaling in palate formation.
    Levi G; Mantero S; Barbieri O; Cantatore D; Paleari L; Beverdam A; Genova F; Robert B; Merlo GR
    Mech Dev; 2006 Jan; 123(1):3-16. PubMed ID: 16330189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Msx-1 is suppressed in bisphosphonate-exposed jaw bone analysis of bone turnover-related cell signalling after bisphosphonate treatment.
    Wehrhan F; Hyckel P; Amann K; Ries J; Stockmann P; Schlegel K; Neukam F; Nkenke E
    Oral Dis; 2011 May; 17(4):433-42. PubMed ID: 21366807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential impact of MSX1 and MSX2 homeogenes on mouse maxillofacial skeleton.
    Berdal A; Molla M; Hotton D; Aïoub M; Lézot F; Néfussi JR; Goubin G
    Cells Tissues Organs; 2009; 189(1-4):126-32. PubMed ID: 18769023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential and overlapping expression domains of Dlx-2 and Dlx-3 suggest distinct roles for Distal-less homeobox genes in craniofacial development.
    Robinson GW; Mahon KA
    Mech Dev; 1994 Dec; 48(3):199-215. PubMed ID: 7893603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Could zoledronic acid prevent root resorption in replanted rat molar?
    Yoo JE; Kim MS; Kwon YD; Kim EC; Kim KC; Choi SC
    Dent Traumatol; 2015 Dec; 31(6):465-70. PubMed ID: 26149469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ozone Improved Bone Dynamic of Female Rats Using Zoledronate.
    Lima Neto TJ; Delanora LA; Sá Simon ME; Carmo Ribeiro KH; Matsumoto MA; Quírino Louzada MJ; Shibli JA; Ervolino E; Faverani LP
    Tissue Eng Part C Methods; 2024 Jan; 30(1):1-14. PubMed ID: 37933908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of chronic zoledronate usage on the jaw and long bones evaluated using RANKL and osteoprotegerin levels in an animal model.
    Çankaya M; Cizmeci Şenel F; Kadioglu Duman M; Muci E; Dayisoylu EH; Balaban F
    Int J Oral Maxillofac Surg; 2013 Sep; 42(9):1134-9. PubMed ID: 23522850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zoledronic acid prevents osteopenia and increases bone strength in a rabbit model of distraction osteogenesis.
    Little DG; Smith NC; Williams PR; Briody JN; Bilston LE; Smith EJ; Gardiner EM; Cowell CT
    J Bone Miner Res; 2003 Jul; 18(7):1300-7. PubMed ID: 12854841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimulation of osteogenic differentiation in stromal cells of giant cell tumour of bone by zoledronic acid.
    Yang T; Zheng XF; Li M; Lin X; Yin QS
    Asian Pac J Cancer Prev; 2013; 14(9):5379-83. PubMed ID: 24175830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tibial bone versican content decreases with zoledronate treatment in adult mice.
    Maurice SB; Bell T; Daniels T; Fetterly CR; Nelson DR; Winwood PJ; Bourque WT; Harris RL
    Osteoporos Int; 2014 Jul; 25(7):1975-81. PubMed ID: 24839166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dlx homeobox gene control of mammalian limb and craniofacial development.
    Kraus P; Lufkin T
    Am J Med Genet A; 2006 Jul; 140(13):1366-74. PubMed ID: 16688724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Additive effects of zoledronic acid and propranolol on bone density and biochemical markers of bone turnover in osteopenic ovariectomized rats.
    Khajuria DK; Razdan R; Mahapatra DR
    Rev Bras Reumatol; 2015; 55(2):103-12. PubMed ID: 25582996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zoledronic acid-induced cytotoxicity through endoplasmic reticulum stress triggered REDD1-mTOR pathway in breast cancer cells.
    Lan YC; Chang CL; Sung MT; Yin PH; Hsu CC; Wang KC; Lee HC; Tseng LM; Chi CW
    Anticancer Res; 2013 Sep; 33(9):3807-14. PubMed ID: 24023313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of combined local treatment with zoledronic acid and basic fibroblast growth factor on implant fixation in ovariectomized rats.
    Gao Y; Luo E; Hu J; Xue J; Zhu S; Li J
    Bone; 2009 Feb; 44(2):225-32. PubMed ID: 19056525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of matrix macromolecules and functional properties of breast cancer cells are modulated by the bisphosphonate zoledronic acid.
    Dedes PG; Gialeli Ch; Tsonis AI; Kanakis I; Theocharis AD; Kletsas D; Tzanakakis GN; Karamanos NK
    Biochim Biophys Acta; 2012 Dec; 1820(12):1926-39. PubMed ID: 22884656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MOZ directs the distal-less homeobox gene expression program during craniofacial development.
    Vanyai HK; Garnham A; May RE; McRae HM; Collin C; Wilcox S; Smyth GK; Thomas T; Voss AK
    Development; 2019 Jul; 146(14):. PubMed ID: 31340933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disruption of Msx-1 and Msx-2 reveals roles for these genes in craniofacial, eye, and axial development.
    Foerst-Potts L; Sadler TW
    Dev Dyn; 1997 May; 209(1):70-84. PubMed ID: 9142497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.